CPH
Click for more information
0.00% 0.9¢ creso pharma limited

Ann: Creso reports first revenues from cannaQIX and anibidiol, page-10

  1. Arthur A
    2,547 Posts.
    lightbulb Created with Sketch. 244
    clock Created with Sketch.
    27/02/18
    12:50
    Post #: 31378063
    Yes, there could be more detail, and more will come in time.

    Excellent indication of rapid up take by market. Excellent confirmation of fulfilling steps, successfully, with excellent partners, building a framework and standard for global expansion.

    Very happy.
    CPH Price at posting: 92.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.